Independent Advisor Alliance Bio N Tech Se Transaction History

Independent Advisor Alliance

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$123.25 - $186.24 $165,524 - $250,120	-1,343 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$126.25 - $231.85 $38,127 - $70,018	-302 Reduced 18.36%	1,343 $229,000
Q4 2021 Feb 11, 2022	SELL	$216.64 - $362.52 $8,665 - $14,500	-40 Reduced 2.37%	1,645 $424,000
Q3 2021 Nov 01, 2021	SELL	$205.93 - $447.23 $3,088 - $6,708	-15 Reduced 0.88%	1,685 $460,000
Q2 2021 Aug 12, 2021	BUY	$113.32 - $241.49 $192,644 - $410,533	1,700 New	1,700 $381,000
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $1.56 Million - $2.17 Million	-18,194 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$72.71 - $129.54 $1.32 Million - $2.36 Million	18,194 New	18,194 $1.48 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

Stay updated on Independent Advisor Alliance with notifications on news.